Arnica E Planta tota D 12 ampoules, 10X1 ml

Areas of application

This medicine is used according to the anthroposophical knowledge of humanity and nature.It serves to stimulate and harmonize the metabolic and form processes in the event of tissue and organ damage, especially after external mechanical influences and poor blood circulation.These include, for example, restrictions on voluntary mobility, sore muscles, strains and bruises.It can also be used for follow-up treatment after a heart attack, after-treatment after a stroke (apoplexy), accompanying treatment for angina pectoris, concussion, long-term effects of psychological shock experiences and accompanying treatment for multiple sclerosis.

Active ingredient and composition

The active ingredient of this medicine is Arnica montana e planta tota ferm 33c.One ampoule contains Arnica montana e planta tota ferm 33c Dil.D12 1 ml (HAB, Vs. 33c).

Contraindications

This medicine should not be used if you are hypersensitive to arnica and other composite plants.

Dosage and method of administration

Unless otherwise prescribed, the dosage is as follows:

Children under 6 years of age receive 0.5 ml injected subcutaneously twice a week.Children from 6 to under 12 years of age receive 0.5-1 ml injected subcutaneously twice a week.Adults and children aged 12 and over receive 1 ml injected subcutaneously twice a week.

Duration of application

Treatment of an acute illness should be completed after two weeks.If there is no improvement within three days, you should see a doctor.The duration of treatment for chronic diseases requires consultation with the doctor.

Side effects

Hypersensitivity reactions may occur in sensitized people.In this case, you should stop taking the medicine and consult a doctor.

Content

The medicine contains 10 ampoules of 1 ml each.

Pharmaceutical entrepreneur and manufacturer

WALA Remedy GmbH, Dorfstraße 1, 73087 Bad Boll/Eckwälden.

Available without a prescription

No prescription is required for this product.

Notes

This leaflet was last revised in January 2018.